PTC Therapeutics Inc
SWB:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PTC Therapeutics Inc
SWB:BH3
|
US |
|
Alliance Entertainment Holding Corp
NASDAQ:AENT
|
US |
|
Aspen Pharmacare Holdings Ltd
F:LDZA
|
ZA |
|
Laboratorio Reig Jofre SA
LSE:0RB1
|
ES |
|
Singapore Post Ltd
SGX:S08
|
SG |
|
K
|
Kofola CeskoSlovensko as
PSE:KOFOL
|
CZ |
|
M
|
Maat Pharma SA
PAR:MAAT
|
FR |
|
OMV AG
LSE:0MKH
|
AT |
|
S
|
Salesforce Inc
SWB:FOO
|
US |
|
MGM Resorts International
NYSE:MGM
|
US |
|
Iberdrola SA
OTC:IBDSF
|
ES |
|
D
|
Da Ming International Holdings Ltd
F:DM7
|
CN |
|
Trade Desk Inc
NASDAQ:TTD
|
US |
|
F
|
Fresnillo PLC
DUS:FNL
|
MX |
|
B
|
Berkshire Hathaway Inc
SWB:BRYN
|
US |
|
Z
|
Zijin Mining Group Co Ltd
XMUN:FJZ
|
CN |
|
N
|
Nike Inc
XBER:NKE
|
US |
|
A
|
Alibaba Health Information Technology Ltd
F:TWYA
|
HK |
|
Quest Diagnostics Inc
NYSE:DGX
|
US |
|
COSCO Shipping Holdings Co Ltd
OTC:CICOY
|
CN |
|
R
|
Royal Gold Inc
LSE:0KXS
|
US |
|
D
|
DaVita Inc
XMUN:TRL
|
US |
|
Daiwa House Industry Co Ltd
OTC:DWAHF
|
JP |
|
Aryzta AG
SIX:ARYN
|
CH |
Wall St Price Targets
BH3 Price Targets Summary
PTC Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for BH3 is 80.32 EUR with a low forecast of 56.85 EUR and a high forecast of 112.75 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BH3's stock price target?
Price Target
80.32
EUR
According to Wall Street analysts, the average 1-year price target for BH3 is 80.32 EUR with a low forecast of 56.85 EUR and a high forecast of 112.75 EUR.
What is the Revenue forecast for PTC Therapeutics Inc?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 3 years is -2%.
What is the Gross Profit forecast for PTC Therapeutics Inc?
Projected CAGR
-5%
The compound annual growth rate for Gross Profit over the next 3 years is -5%.
What is the Operating Income forecast for PTC Therapeutics Inc?
Projected CAGR
-12%
The compound annual growth rate for Operating Income over the next 3 years is -12%.
What is the Pre-Tax Income forecast for PTC Therapeutics Inc?
Projected CAGR
-20%
The compound annual growth rate for Pre-Tax Income over the next 3 years is -20%.
What is the Net Income forecast for PTC Therapeutics Inc?
Projected CAGR
-20%
Over the last 13 years, the compound annual growth rate for Net Income has been 70%. The projected CAGR for the next 3 years is -20%.
